# AINewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Appoints Dr. Joel Gagnier as Chief Science Officer to Advance AI-Driven Health Research

Fifty 1 Labs (OTC: FITY), a cutting-edge innovator at the intersection of artificial intelligence, clinical research, and personalized wellness, announced the appointment of Dr. Joel Gagnier, BA, ND, MSc, PhD, as Chief Science Officer. A recognized leader in clinical epidemiology and research methodology, Dr. Gagnier currently serves as Associate Professor in Epidemiology & Biostatistics and Surgery at Western University’s Schulich School of Medicine & Dentistry. His expertise in clinical trial design, bias reduction, and patient-reported outcome measures (PROMs) strengthens Fifty1 AI Labs’ commitment to rigorous, evidence-based research, positioning the company to advance AI-driven solutions in musculoskeletal health, pain management, and personalized wellness.

 To view the full press release, visit https://ibn.fm/zu1Iq

 About Fifty1 AI Labs

 Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), is redefining drug discovery by using AI to unlock new potential in proven medicines. By repurposing safe, off-patent compounds, we accelerate smarter therapies that improve lives, reduce costs, and create lasting value for patients, partners, and forward-thinking investors.

 For more information, visit the company’s website at https://fifty1labs.com/

 About AINewsWire

 AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

 AINW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit www.AINewsWire.com

 Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

 AINewsWireAustin, Texaswww.AINewsWire.com512.354.7000 OfficeEditor@AINewsWire.com

 AINewsWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/ainw/ainewsbreaks-fifty-1-labs-inc-otc-fity-appoints-dr-joel-gagnier-as-chief-science-officer-to-advance-ai-driven-health-research/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/fifty1-ai-labs-appoints-dr-joel-gagnier-as-chief-science-officer/07688d970705973b7f15e908a052728d) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202510/248142-fifty-1-labs-appoints-dr-joel-gagnier-as-chief-science-officer-to-strengthen-ai-driven-health-research)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202510/248143-fifty-1-labs-nombra-al-dr-joel-gagnier-como-director-cientifico-para-impulsar-investigacion-en-salud-con-ia)

Pickup - [https://platzennachrichten.de/nachrichten](https://platzennachrichten.de/nachrichten/202510/248151-fifty-1-labs-ernennt-dr-joel-gagnier-zum-chief-science-officer-fur-ki-gestutzte-gesundheitsforschung)

Pickup - [https://actueclair.com](https://actueclair.com/202510/248150-fifty-1-labs-nomme-le-dr-joel-gagnier-au-poste-de-directeur-scientifique-pour-renforcer-la-recherche-en-sante-pilotee-par-l-ia)

Pickup - [https://faqstaq.news/news](https://faqstaq.news/news/202510/248161-faq-dr-joel-gagnier-s-appointment-as-chief-science-officer-at-fifty-1-labs-and-ai-driven-health-research)

Pickup - [https://goinvest.com/ibn-faqstaq](https://goinvest.com/ibn-faqstaq/202510/248125-faq-dr-joel-gagnier-s-appointment-as-chief-science-officer-at-fifty-1-labs-and-ai-driven-health-research)
 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/2510/9/glueKIN4.webp)